UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease

Neurology, 1998-05, Vol.50 (5), p.1323-1326

1998

Volltextzugriff (PDF)

Huntington's disease: a randomized, controlled trial using the NMDA-antagonist amantadine

Neurology, 2002-09, Vol.59 (5), p.694-699

2002

Volltextzugriff (PDF)

Levodopa-induced dyskinesias improved by a glutamate antagonist in parkinsonian monkeys

Annals of neurology, 1996-05, Vol.39 (5), p.574-578

1996

Volltextzugriff (PDF)

Antiparkinsonian and antidyskinetic activity of drugs targeting central glutamatergic mechanisms

Journal of neurology, 2000-04, Vol.247 Suppl 2 (S2), p.II36-II42

2000

Volltextzugriff (PDF)

Dextromethorphan improves levodopa-induced dyskinesias in Parkinson's disease

Neurology, 1998-07, Vol.51 (1), p.203-206

1998

Volltextzugriff (PDF)

Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys

Movement disorders, 1998-09, Vol.13 (5), p.798-802

1998

Volltextzugriff (PDF)

Neostriatal mechanisms in Parkinson's disease

Neurology, 1998-08, Vol.51 (2 Suppl 2), p.S30

1998

Volltextzugriff (PDF)

Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study

Movement disorders, 2001-05, Vol.16 (3), p.515-520

2001

Volltextzugriff (PDF)

Wearing-off fluctuations in Parkinson's disease: Contribution of postsynaptic mechanisms

Annals of neurology, 1994-07, Vol.36 (1), p.27-31

1994

Volltextzugriff (PDF)

Apomorphine responses in Parkinson's disease and the pathogenesis of motor complications

Neurology, 1997-02, Vol.48 (2), p.369-372

1997

Volltextzugriff (PDF)

Changed distribution pattern of the constitutive rather than the inducible HSP70 chaperone in neuromelanin-containing neurones of the Parkinsonian midbrain

Neuropathology and applied neurobiology, 2006-04, Vol.32 (2), p.157-169

2006

Volltextzugriff (PDF)

Adenosine A(2A) receptor antagonist treatment of Parkinson's disease

Neurology, 2003-08, Vol.61 (3), p.293

2003

Volltextzugriff (PDF)

Catechol-O-methyltransferase inhibitor tolcapone prolongs levodopa/carbidopa action in parkinsonian patients

Neurology, 1993-12, Vol.43 (12), p.2685-2685

1993

Volltextzugriff (PDF)

The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Preliminary Clinical Validity

Journal of clinical and experimental neuropsychology, 1998-06, Vol.20 (3), p.310-319

1998

Volltextzugriff (PDF)

Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models

Neurology, 2001-11, Vol.57 (10), p.1829-1834

2001

Volltextzugriff (PDF)

A trial of dextromethorphan in parkinsonian patients with motor response complications

Movement disorders, 1998-05, Vol.13 (3), p.414-417

1998

Volltextzugriff (PDF)

Cortical and subcortical chemical pathology in Alzheimer's disease as assessed by multislice proton magnetic resonance spectroscopic imaging

Neurology, 1996-09, Vol.47 (3), p.696-704

1996

Volltextzugriff (PDF)

Dopaminergic effects on simple and choice reaction time performance in Parkinson's disease

Neurology, 1988-02, Vol.38 (2), p.249-249

1988

Volltextzugriff (PDF)

Pathogenesis of dyskinesias in parkinson's disease

Annals of neurology, 1989-05, Vol.25 (5), p.523-526

1989

Volltextzugriff (PDF)

Striatal mechanisms and pathogenesis of parkinsonian signs and motor complications

Annals of neurology, 2000-04, Vol.47 (4 Suppl 1), p.S122

2000

Volltextzugriff (PDF)

Effects of supra-threshold levodopa doses on dyskinesias in advanced Parkinson's disease

Neurology, 1997-09, Vol.49 (3), p.711-713

1997

Volltextzugriff (PDF)

AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys

Neurology, 2000-04, Vol.54 (8), p.1589

2000

Volltextzugriff (PDF)

Effects of the full dopamine D1 receptor agonist dihydrexidine in Parkinson's disease

Clinical neuropharmacology, 1998-11, Vol.21 (6), p.339-343

1998

Volltextzugriff (PDF)

Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease

Annals of neurology, 1990-01, Vol.27 (1), p.18-23

1990

Volltextzugriff (PDF)

Differential memory and executive functions in demented patients with Parkinson's and Alzheimer's disease

Journal of neurology, neurosurgery and psychiatry, 1991-01, Vol.54 (1), p.25-29

1991

Volltextzugriff (PDF)

1 – 25 von 218

Suche als RSS-Feed

Aktive Filter

ThemaClinical Neurology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(183)
Mit Volltextzugriff
(113)

Publikationsform

Artikel
(218)

Sprache

Englisch
(218)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(218)
Neurosciences & Neurology
(218)
Science & Technology
(218)
Humans
(177)
Middle Aged
(131)
Male
(126)
Female
(117)
Biological And Medical Sciences
(113)
Medical Sciences
(111)
Aged
(94)
Parkinson Disease - Drug Therapy
(74)
Adult
(69)
Pharmacology. Drug Treatments
(67)
Neuropharmacology
(55)
Neurology
(51)
Neurosciences
(50)
Double-Blind Method
(40)
Anticonvulsants. Antiepileptics. Antiparkinson Agents
(37)
Levodopa - Therapeutic Use
(37)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease

Huntington's disease: a randomized, controlled trial using the NMDA-antagonist amantadine

Levodopa-induced dyskinesias improved by a glutamate antagonist in parkinsonian monkeys

Antiparkinsonian and antidyskinetic activity of drugs targeting central glutamatergic mechanisms

Dextromethorphan improves levodopa-induced dyskinesias in Parkinson's disease

Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys

Neostriatal mechanisms in Parkinson's disease

Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study

Wearing-off fluctuations in Parkinson's disease: Contribution of postsynaptic mechanisms

Apomorphine responses in Parkinson's disease and the pathogenesis of motor complications

Changed distribution pattern of the constitutive rather than the inducible HSP70 chaperone in neuromelanin-containing neurones of the Parkinsonian midbrain

Adenosine A(2A) receptor antagonist treatment of Parkinson's disease

Catechol-O-methyltransferase inhibitor tolcapone prolongs levodopa/carbidopa action in parkinsonian patients

The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Preliminary Clinical Validity

Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models

A trial of dextromethorphan in parkinsonian patients with motor response complications

Cortical and subcortical chemical pathology in Alzheimer's disease as assessed by multislice proton magnetic resonance spectroscopic imaging

Dopaminergic effects on simple and choice reaction time performance in Parkinson's disease

Pathogenesis of dyskinesias in parkinson's disease

Striatal mechanisms and pathogenesis of parkinsonian signs and motor complications

Effects of supra-threshold levodopa doses on dyskinesias in advanced Parkinson's disease

AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys

Effects of the full dopamine D1 receptor agonist dihydrexidine in Parkinson's disease

Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease

Differential memory and executive functions in demented patients with Parkinson's and Alzheimer's disease

Aktive Filter

Suchergebnisse filtern